Laura A. Varas

512 total citations
15 papers, 385 citations indexed

About

Laura A. Varas is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Laura A. Varas has authored 15 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Oncology. Recurrent topics in Laura A. Varas's work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Mesenchymal stem cell research (2 papers). Laura A. Varas is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Mesenchymal stem cell research (2 papers). Laura A. Varas collaborates with scholars based in Cuba, Sweden and United States. Laura A. Varas's co-authors include Christian Kjellman, Lars Ohlsson, Klaus Edvardsen, Magnus Lindvall, Andreas Olsson, Vladimir Besada, Johan Richter, Therése Bengtsson, Gabriella Honeth and Robert Bockermann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Vaccine.

In The Last Decade

Laura A. Varas

14 papers receiving 374 citations

Peers

Countries citing papers authored by Laura A. Varas

Since Specialization

Citations

This map shows the geographic impact of Laura A. Varas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Varas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Varas more than expected).

Fields of papers citing papers by Laura A. Varas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura A. Varas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Varas. The network helps show where Laura A. Varas may publish in the future.

Co-authorship network of co-authors of Laura A. Varas

This figure shows the co-authorship network connecting the top 25 collaborators of Laura A. Varas. A scholar is included among the top collaborators of Laura A. Varas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura A. Varas. Laura A. Varas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform 2025 ·Drug Delivery ·(unknown), Karin Hägerbrand, Laura A. Varas, Anette Gjörloff Wingren, Mats Ohlin, Peter Ellmark, Laura von Schantz	1
2	ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1 2023 ·Cancer Immunology Immunotherapy ·(unknown), Sara Fritzell, Anneli Nilsson, Karin Barchan, Anna Rosén, Lena Schultz, Laura A. Varas, (unknown), (unknown), M. Håkansson, Laura von Schantz, Peter Ellmark	6
3	751 Neo-X-Prime bispecific antibodies targeting CD40 and tumor antigens promote cross-presentation of tumor exosome-derived neoantigen and induce superior anti-tumor responses compared to CD40 mAb 2021 ·SHILAP Revista de lepidopterología ·Karin Hägerbrand, (unknown), Laura von Schantz, Laura A. Varas, (unknown), Adnan Deronic, Anette Sundstedt, (unknown), Karin Barchan, (unknown), Anna Rosén, (unknown), Eva Lindqvist, (unknown), Peter Ellmark	0
4	858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies 2020 ·SHILAP Revista de lepidopterología ·Peter Ellmark, Karin Hägerbrand, (unknown), Laura von Schantz, Adnan Deronic, Laura A. Varas, (unknown), Karin Barchan, (unknown), (unknown), (unknown), Anna Rosén, (unknown), Malin Lindstedt	4
5	Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate 2019 ·Vaccine ·(unknown), (unknown), (unknown), (unknown), (unknown), Laura A. Varas, (unknown), (unknown), Miladys Limonta‐Fernández, Isis Torréns	4
6	Biological activity of LALF32-51–E7, a vaccine candidate for the treatment of anogenital lesions associated to HPV16 2018 ·(unknown), (unknown), (unknown), (unknown), Miladys Limonta‐Fernández, (unknown), (unknown), (unknown), Laura A. Varas, Isis Torréns	1
7	LALF32-51-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs 2017 ·Clinical & Experimental Metastasis ·(unknown), (unknown), (unknown), (unknown), José Antonio Suárez, Nelsón Merino, (unknown), (unknown), (unknown), Laura A. Varas, (unknown), Miladys Limonta‐Fernández, (unknown), (unknown), Isis Torréns	4
8	The LALF32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response 2015 ·(unknown), (unknown), Maribel Guerra Vallespí, (unknown), (unknown), (unknown), Miladys Limonta‐Fernández, (unknown), Laura A. Varas, Isis Torréns	5
9	Recombinant expression of ShPI-1A, a non-specific BPTI-Kunitz-type inhibitor, and its protection effect on proteolytic degradation of recombinant human miniproinsulin expressed in Pichia pastoris 2011 ·FEMS Yeast Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Laura A. Varas, (unknown), María Á. Chávez, (unknown), (unknown)	14
10	α 10 Integrin Expression Is Up-Regulated on Fibroblast Growth Factor-2-Treated Mesenchymal Stem Cells with Improved Chondrogenic Differentiation Potential 2007 ·Stem Cells and Development ·Laura A. Varas, Lars Ohlsson, Gabriella Honeth, Andreas Olsson, Therése Bengtsson, Charlotte Wiberg, Robert Bockermann, Sofia Järnum, Johan Richter, Douglas Pennington, Brian Johnstone, Evy Lundgren-Åkerlund, Christian Kjellman	76
11	Expression, purification and characterization of porcine pancreatic Carboxypeptidase B from Pichia pastoris for the conversion of recombinant human insulin 2006 ·Enzyme and Microbial Technology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laura A. Varas, Francesc Avilés	6
12	Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast 2006 ·Biochemical and Biophysical Research Communications ·(unknown), Nelson Acosta‐Rivero, (unknown), Alexis Musacchio, Ariel Vina-Rodrı́guez, (unknown), (unknown), (unknown), José L. Garcı́a, Laura A. Varas, Verena Muzio, Santiago Dueñas‐Carrera	18
13	Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris 2005 ·Biotechnology Letters ·(unknown), (unknown), (unknown), (unknown), Laura A. Varas, (unknown), (unknown), (unknown), (unknown), Vladimir Besada, (unknown), (unknown), Lila Castellanos, (unknown)	82
14	Modeling of mini-proinsulin production in Pichia pastoris using the AOX promoter 2003 ·Biotechnology Letters ·(unknown), Laura A. Varas, Jorge Valdés, (unknown), (unknown), (unknown)	19
15	Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix 2003 ·Experimental and Molecular Pathology ·Lars Ohlsson, Laura A. Varas, Christian Kjellman, Klaus Edvardsen, Magnus Lindvall	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact